John A Zic
Affiliation: Vanderbilt University
- The treatment of cutaneous T-cell lymphoma with photopheresisJohn A Zic
Vanderbilt University, Division of Dermatology, Nashville, Tennessee 37232 5227, USA
Dermatol Ther 16:337-46. 2003..Efforts to establish the effectiveness of combining ECP with other newer immunoadjuvant therapies and modifications of the procedure to enhance immunomodulation are exciting prospects for patients with CTCL...
- Open-label pilot study of combination therapy with rosiglitazone and bexarotene in the treatment of cutaneous T-cell lymphomaJacob A Sepmeyer
Vanderbilt University School of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232 5227, USA
J Am Acad Dermatol 56:584-7. 2007..After 16 weeks of combination therapy, skin score decreased in two patients. Pruritus was alleviated in 3 of 4 patients, whereas quality of life was unchanged. Adverse events included hyperlipidemia, anemia, neutropenia, and lymphopenia...
- Gadolinium deposition in nephrogenic fibrosing dermopathyAlan S Boyd
Department of Medicine Dermatology, Vanderbilt University, Nashville, TN 37232, USA
J Am Acad Dermatol 56:27-30. 2007..The pathogenesis of this entity remains unclear; however, our recent observations suggest a likely mechanism for the initial dermal manifestations of this gadolinium toxicity...
- miR-223 regulates cell growth and targets proto-oncogenes in mycosis fungoides/cutaneous T-cell lymphomaLaura Y McGirt
Department of Medicine Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee, USA
J Invest Dermatol 134:1101-7. 2014..Thus, miR-223 and its targets may be useful for the development of new therapeutics for MF/CTCL. ..
- Photopheresis in the treatment of cutaneous T-cell lymphoma: current statusJohn A Zic
Division of Dermatology, Vanderbilt University School of Medicine, Nashville, Tennessee 37204, USA
Curr Opin Oncol 24:S1-10. 2012..In addition, there has been progress in understanding how ECP works at the cellular level...
- Controversies in the management of the cutaneous T cell lymphomasJohn A Zic
Vanderbilt University School of Medicine, Nashville, Tennessee 37232 5227, USA
Dermatol Ther 22:407-17. 2009..When using the systemic agents, a "start low and go slow" strategy may offer patients several advantages. Dermatologists are uniquely trained to diagnose and to manage all but the most advanced stage patients with CTCL...
- Conjugal transformed mycosis fungoides: the unknown role of viral infection and environmental exposures in the development of cutaneous T-cell lymphomaAdriana N Schmidt
Division of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee, USA
J Am Acad Dermatol 54:S202-5. 2006..Future studies should aim to clarify the potential role of infectious agents, such as human T-lymphotropic virus I and II, cytomegalovirus, Epstein-Barr virus, and other environmental exposures, in the development of MF...
- Large B-cell lymphoma of the leg: clinical and pathologic characteristics in a North American seriesBeth L Brogan
Departments of Medicine, Vanderbilt University Medical School, Nashville, Tennessee 37232 5227, USA
J Am Acad Dermatol 49:223-8. 2003..Large B-cell lymphoma (LBCL) of the leg is an uncommon subset of primary cutaneous B-cell lymphoma that has been described in a series of European patients...